Topics:

Lung Cancer

Lung Cancer

CMS released their final decision for lung cancer screening with low-dose CT.

A new study clarifies the link between metformin and lung cancer. Perhaps not surprisingly, a smoking habit (or lack of it) substantially affects risk.

NCCN Group 2 high-risk patients to benefit from CT lung screening, study says.

Patients who underwent low-dose CT for lung cancer screening and received false-positives benefited from counseling.

Epidermal growth factor receptor tyrosine kinase inhibitors may not be the best option for some patients with nonsmall cell lung cancer, but an ALK inhibitor, crizotinib, proves a winner.

GlaxoSmithKline has stopped a phase III trial of a novel lung cancer immunotherapeutic agent, after determining that it may not be possible to identify which genetic subgroups may benefit from the treatment.

A biomarker and five clinical factors help to predict which patients with nonsmall-cell lung cancer are at high risk for lung inflammation after radiotherapy.

Pages

Subscribe to Lung Cancer on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.